As one of the most common cancers, 1 out of every 7 women in the UK will face a breast cancer diagnosis in their lifetime.
As one of the most common cancers, 1 out of every 7 women in the UK will face a breast cancer diagnosis in their lifetime.
For young men who identify as black and minority ethnic (BME), mental health is not always an easy topic to discuss. Many feel restricted by fear, stigma and barriers inside and outside of the communities they are part of. For some, the available support isn’t appropriate for their needs.
World Mental Health Day is an opportunity to reflect on what needs to change, but also to celebrate the people who are working to make sure positive change happens. Like Dr Lindsay Dewa, IGHI Research Fellow and mental health expert.
We caught up with Lindsay to find out about her mental health research, her path into academia, and why she’s excited about what the future might hold.
IGHI is home to a team of staff who are skilled and passionate about their roles. Our talented people are the reason we’re able to tackle some of the most pressing global health challenges through cutting-edge innovation.
By Dr Sara Garfield, Research Associate, NIHR Imperial Patient Safety Translational Research Centre, Institute of Global Health Innovation
At IGHI’s NIHR Imperial Patient Safety Translational Research Centre, I lead research projects relating to the role that patients and carers can play in making sure medicines are used safely.
“No test is better than a bad test,” said Matt Hancock.
While we may tire of hearing slogans, the principle here is important.
Coronavirus antibody tests have been hailed as a game-changer for the pandemic and a way forward as we traverse these uncertain times. Antibodies are Y-shaped immune molecules produced by the body in response to an infection. They latch onto the offender – such as coronavirus – in a bid to thwart it. Your body keeps a record of the encounter, so that if it comes across the same pathogen in the future, it can quickly make more antibodies and launch an effective attack.
IGHI is home to a team of staff who are skilled and passionate about their roles. Our talented people are the reason we’re able to tackle some of the most pressing global health challenges through cutting-edge innovation.
According to the Department for Transport, between June 2017-18, 1,770 people lost their lives due to a road traffic collision in Great Britain.
But this isn’t an issue that only affects developed countries. It’s a global problem with many low-and-middle-income countries having even higher numbers of victims. Road traffic incidents can result in the loss of loved ones for families and friends, and for those who do survive, they can mean sustaining life-changing injuries and trauma. These impacts stretch beyond the individual, affecting economies and put pressure on health systems.
It’s been almost a month since Imperial PhD student Sam Tukra won IGHI’s Student Challenges Competition (SCC).
His healthcare innovation, Third Eye Intelligence, an artificial intelligence (AI) driven platform that predicts a patient’s risk of organ failure impressed the competition judges. Sam’s pitch earnt him the top prize of £10,000. But behind every start-up, there is a journey full of twists and turns.
Digital technology has been poised to transform the way that healthcare is delivered. Yet uptake and implementation has been slow; in the UK alone for example, almost a quarter of hospitals still use paper rather than electronic records.
But when COVID-19 hit, health systems were forced to rapidly adapt and use technology to deliver care remotely, where face to face appointments were no longer possible. While it’s impossible to predict when the COVID crisis will be over, will remote care become the ‘new normal’ post-pandemic? And if digital-first health technologies are here to stay, what are the implications for patients?
Newly launched IGHI research, supported by Imperial’s COVID-19 Response Fund, will explore these important questions.